Literature DB >> 14661064

Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour.

Carla Oliveira1, Joyce de Bruin, Sérgio Nabais, Marjolijn Ligtenberg, Cátia Moutinho, Fokko M Nagengast, Raquel Seruca, Han van Krieken, Fátima Carneiro.   

Abstract

Mutations in CDH1, encoding E-cadherin, are the underlying genetic defect in approximately one-third of the hereditary diffuse gastric cancer (HDGC) families described so far. Tumours arising in these families show abnormal or absence of E-cadherin expression, following the model of tumour suppressor gene inactivation. A single study has been reported showing inactivation of the CDH1 wild-type allele in tumour cells from HDGC families either by promoter methylation or by somatic mutation. In order to find the genetic alteration responsible for the presence of diffuse gastric cancers in four members of a Caucasian family, we have screened the coding sequence of CDH1 for germline mutations and searched for the second inactivating hit in the tumour samples. In this family, we have found a germline splice-site mutation in all members affected by gastric cancer and, in one tumour, a somatic deletion affecting at least exon 8 of CDH1. Our results show that a CDH1 intragenic deletion is the second hit inactivating the wild-type allele, in one of the tumours in this family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14661064     DOI: 10.1038/sj.onc.1207335

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

Review 1.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

2.  Mutation screen and RNA analysis disclose the changed splicing of the E-cadherin transcription in gastric cancer.

Authors:  Xiaowei Li; Yafan Gao; Yiyuan Pan; Yan Pan; Lifeng Wang; Nong Xiao; Qiong He; Yimei Fan; Yaping Wang
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

3.  CDH1/E-cadherin germline mutations in early-onset gastric cancer.

Authors:  J T Bacani; M Soares; R Zwingerman; N di Nicola; J Senz; R Riddell; D G Huntsman; S Gallinger
Journal:  J Med Genet       Date:  2006-06-26       Impact factor: 6.318

Review 4.  Hereditary gastric cancer.

Authors:  F Carneiro
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

5.  Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer.

Authors:  T Frebourg; C Oliveira; P Hochain; R Karam; S Manouvrier; C Graziadio; M Vekemans; A Hartmann; S Baert-Desurmont; C Alexandre; S Lejeune Dumoulin; C Marroni; C Martin; S Castedo; M Lovett; J Winston; J C Machado; T Attié; E W Jabs; J Cai; Ph Pellerin; J P Triboulet; M Scotte; F Le Pessot; A Hedouin; F Carneiro; M Blayau; R Seruca
Journal:  J Med Genet       Date:  2005-04-14       Impact factor: 6.318

Review 6.  Hereditary diffuse gastric cancer: What the clinician should know.

Authors:  Ryan Ying Cong Tan; Joanne Ngeow
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

7.  Genetic screening for familial gastric cancer.

Authors:  Carla Oliveira; Gianpaolo Suriano; Paulo Ferreira; Paulo Canedo; Pardeep Kaurah; Rita Mateus; Ana Ferreira; António C Ferreira; Maria José Oliveira; Céu Figueiredo; Fátima Carneiro; Gisela Keller; David Huntsman; José Carlos Machado; Raquel Seruca
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

8.  Germline E-cadherin mutations in familial lobular breast cancer.

Authors:  S Masciari; N Larsson; J Senz; N Boyd; P Kaurah; M J Kandel; L N Harris; H C Pinheiro; A Troussard; P Miron; N Tung; C Oliveira; L Collins; S Schnitt; J E Garber; D Huntsman
Journal:  J Med Genet       Date:  2007-07-27       Impact factor: 6.318

Review 9.  Molecular alterations in gastric cancer with special reference to the early-onset subtype.

Authors:  Małgorzata Skierucha; Anya Na Milne; G Johan A Offerhaus; Wojciech P Polkowski; Ryszard Maciejewski; Robert Sitarz
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

10.  A short guide to hereditary diffuse gastric cancer.

Authors:  Parry Guilford; Vanessa Blair; Helen More; Bostjan Humar
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.